Literature DB >> 31440738

Genomic Correlates of Exceptional Response to ErbB3 Inhibition in Head and Neck Squamous Cell Carcinoma.

Daniel L Faden1,2, Roberto Gomez-Casal3, Diego Alvarado4, Umamaheswar Duvvuri3.   

Abstract

Entities:  

Year:  2019        PMID： 31440738      PMCID： PMC6705601          DOI： 10.1200/PO.18.00174

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  18 in total

Review 1.  The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.

Authors:  Dhara N Amin; Marcia R Campbell; Mark M Moasser
Journal:  Semin Cell Dev Biol       Date:  2010-09-09       Impact factor: 7.727

2.  ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.

Authors:  Joyce A Schroeder; Melissa C Adriance; Elizabeth J McConnell; Melissa C Thompson; Barbara Pockaj; Sandra J Gendler
Journal:  J Biol Chem       Date:  2002-04-11       Impact factor: 5.157

3.  Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.

Authors:  Emily J Faivre; Carol A Lange
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

4.  Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma.

Authors:  Eric H L Lee; Raj Chari; Andy Lam; Raymond T Ng; John Yee; John English; Kenneth G Evans; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  Clin Med Oncol       Date:  2008-04-01

Review 5.  Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.

Authors:  Koji Ueno; Hiroshi Hirata; Yuji Hinoda; Rajvir Dahiya
Journal:  Int J Cancer       Date:  2012-08-30       Impact factor: 7.396

6.  A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.

Authors:  Si Tuen Lee-Hoeflich; Lisa Crocker; Evelyn Yao; Thinh Pham; Xander Munroe; Klaus P Hoeflich; Mark X Sliwkowski; Howard M Stern
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

Review 7.  Convergence between Wnt-β-catenin and EGFR signaling in cancer.

Authors:  Tianhui Hu; Cunxi Li
Journal:  Mol Cancer       Date:  2010-09-09       Impact factor: 27.401

8.  Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.

Authors:  Mikiko Takikita; Ran Xie; Joon-Yong Chung; Hanbyoul Cho; Kris Ylaya; Seung-Mo Hong; Christopher A Moskaluk; Stephen M Hewitt
Journal:  J Transl Med       Date:  2011-07-29       Impact factor: 5.531

9.  Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.

Authors:  Natalia V Sergina; Megan Rausch; Donghui Wang; Jimmy Blair; Byron Hann; Kevan M Shokat; Mark M Moasser
Journal:  Nature       Date:  2007-01-07       Impact factor: 49.962

Review 10.  Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?

Authors:  Elizabeth A Musgrove
Journal:  Breast Cancer Res       Date:  2003-10-24       Impact factor: 6.466
View more
  3 in total

1.  Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients.

Authors:  Umamaheswar Duvvuri; Jonathan George; Seungwon Kim; Diego Alvarado; Veronique M Neumeister; Ahmed Chenna; Richard Gedrich; Thomas Hawthorne; Theresa LaVallee; Jennifer R Grandis; Julie E Bauman
Journal:  Clin Cancer Res       Date:  2019-07-15       Impact factor: 12.531

2.  UHRF2 promotes Hepatocellular Carcinoma Progression by Upregulating ErbB3/Ras/Raf Signaling Pathway.

Authors:  Jingjie Sun; Kejia Wu; Siyuan Chen; Shiming Jiang; Yong Chen; Changzhu Duan
Journal:  Int J Med Sci       Date:  2021-06-26       Impact factor: 3.738

3.  Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer.

Authors:  Julie E Bauman; Ricklie Julian; Nabil F Saba; Trisha M Wise-Draper; Douglas R Adkins; Paul O'Brien; Mary Jo Fidler; Michael K Gibson; Umamaheswar Duvvuri; Margo Heath-Chiozzi; Diego Alvarado; Richard Gedrich; Philip Golden; Roger B Cohen
Journal:  Cancers (Basel)       Date:  2022-05-10       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.